New ISB research uses Truveta Data to study treatment for hospitalized pregnant patients with COVID-19
hadlock.isbscience.org/news/2023/07/28/new-isb-research-uses-truveta-data-to-study-treatment-for-hospitalized-pregnant-patients-with-covid-19/
hadlock.isbscience.org/news/2023/07/28/new-isb-research-uses-truveta-data-to-study-treatment-for-hospitalized-pregnant-patients-with-covid-19/ Recent Articles
-
Autoimmune Disease and Pregnancy: ISB Study Challenges Prevailing Wisdom, Unveils Nuances
An ISB-led study showed nuanced pregnancy outcomes for pregnant individuals with autoimmune disease. The findings reinforce that there isn’t a one-size-fits-all approach, and provides important new avenues for further investigation.
-
2023 Year in Review
Throughout 2023, ISB research has been published in impactful peer-reviewed journals and our scientists have been featured in major media outlets and popular podcasts. In this 2023 Year in Review, we showcase some of our most important and interesting highlights of the year.
-
COVID-19 Vaccines and Boosters Are Essential for Maternal-Fetal Health
In light of the recent FDA and CDC decision to approve two updated messenger RNA COVID-19 booster shots, it is imperative to alert the pregnant population of the importance and effectiveness of these vaccines and boosters.
